Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 12 | 2021 | 970 | 1.950 |
Why?
|
| Volatile Organic Compounds | 2 | 2023 | 10 | 0.970 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 42 | 0.930 |
Why?
|
| Faculty, Nursing | 1 | 2023 | 51 | 0.900 |
Why?
|
| Stress, Psychological | 4 | 2019 | 246 | 0.850 |
Why?
|
| Parents | 3 | 2021 | 105 | 0.840 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 89 | 0.810 |
Why?
|
| Epidemics | 1 | 2021 | 4 | 0.810 |
Why?
|
| Electronic Nose | 2 | 2023 | 3 | 0.800 |
Why?
|
| Breath Tests | 2 | 2023 | 11 | 0.800 |
Why?
|
| Patient Care | 1 | 2021 | 34 | 0.780 |
Why?
|
| Nurse's Role | 2 | 2021 | 118 | 0.750 |
Why?
|
| Publications | 1 | 2020 | 14 | 0.740 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 13 | 0.740 |
Why?
|
| Bayes Theorem | 1 | 2020 | 39 | 0.730 |
Why?
|
| Statistics as Topic | 1 | 2020 | 113 | 0.720 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 41 | 0.700 |
Why?
|
| Parenting | 1 | 2019 | 73 | 0.680 |
Why?
|
| Immunosenescence | 1 | 2018 | 4 | 0.660 |
Why?
|
| Fish Oils | 1 | 2018 | 5 | 0.660 |
Why?
|
| Caregivers | 1 | 2019 | 143 | 0.630 |
Why?
|
| Cytokines | 1 | 2018 | 347 | 0.560 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 139 | 0.560 |
Why?
|
| Humans | 34 | 2023 | 29337 | 0.560 |
Why?
|
| Inflammation | 1 | 2018 | 344 | 0.550 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 379 | 0.550 |
Why?
|
| HIV Wasting Syndrome | 2 | 2013 | 3 | 0.510 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 625 | 0.490 |
Why?
|
| Complementary Therapies | 1 | 2012 | 15 | 0.420 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 6 | 0.400 |
Why?
|
| Anticholesteremic Agents | 1 | 2011 | 18 | 0.400 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 13 | 0.400 |
Why?
|
| Mannans | 2 | 2013 | 15 | 0.400 |
Why?
|
| Dyslipidemias | 1 | 2011 | 23 | 0.390 |
Why?
|
| Obesity | 3 | 2013 | 291 | 0.390 |
Why?
|
| Weight Loss | 3 | 2013 | 99 | 0.380 |
Why?
|
| Education, Nursing, Graduate | 1 | 2012 | 89 | 0.380 |
Why?
|
| Dietary Supplements | 5 | 2018 | 53 | 0.320 |
Why?
|
| Double-Blind Method | 4 | 2018 | 503 | 0.320 |
Why?
|
| Anesthesia | 2 | 2021 | 34 | 0.310 |
Why?
|
| Anesthesia, General | 2 | 2019 | 30 | 0.300 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 5 | 0.280 |
Why?
|
| Dietary Fiber | 1 | 2005 | 22 | 0.270 |
Why?
|
| Body Weight | 1 | 2005 | 133 | 0.260 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 19 | 0.260 |
Why?
|
| Lipids | 1 | 2004 | 36 | 0.250 |
Why?
|
| Female | 14 | 2023 | 16197 | 0.250 |
Why?
|
| Enteral Nutrition | 2 | 2004 | 49 | 0.250 |
Why?
|
| Insulin Resistance | 1 | 2004 | 60 | 0.250 |
Why?
|
| Middle Aged | 9 | 2019 | 9823 | 0.240 |
Why?
|
| Child, Preschool | 3 | 2021 | 642 | 0.240 |
Why?
|
| Nonlinear Dynamics | 1 | 2023 | 14 | 0.230 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 92 | 0.230 |
Why?
|
| Adult | 10 | 2019 | 8601 | 0.230 |
Why?
|
| United States | 4 | 2019 | 2333 | 0.220 |
Why?
|
| Arginine | 1 | 2002 | 18 | 0.220 |
Why?
|
| Male | 11 | 2019 | 15621 | 0.220 |
Why?
|
| Hospitalization | 2 | 2016 | 317 | 0.220 |
Why?
|
| Immunity | 1 | 2002 | 24 | 0.220 |
Why?
|
| Advance Care Planning | 1 | 2022 | 16 | 0.210 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 553 | 0.210 |
Why?
|
| Racism | 1 | 2022 | 30 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 90 | 0.210 |
Why?
|
| Nursing Services | 1 | 2021 | 1 | 0.200 |
Why?
|
| Adolescent | 4 | 2019 | 2279 | 0.200 |
Why?
|
| Child | 3 | 2021 | 1346 | 0.200 |
Why?
|
| Nursing Research | 1 | 2021 | 37 | 0.190 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 295 | 0.190 |
Why?
|
| Health Literacy | 1 | 2022 | 102 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 189 | 0.190 |
Why?
|
| Exercise | 3 | 2021 | 468 | 0.190 |
Why?
|
| Organizational Innovation | 1 | 2020 | 19 | 0.190 |
Why?
|
| Exhalation | 1 | 2020 | 3 | 0.190 |
Why?
|
| Physical Fitness | 1 | 2020 | 59 | 0.180 |
Why?
|
| Decision Making | 1 | 2021 | 220 | 0.170 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 15 | 0.170 |
Why?
|
| Cholesterol, HDL | 2 | 2011 | 27 | 0.160 |
Why?
|
| Cholesterol, LDL | 2 | 2011 | 30 | 0.160 |
Why?
|
| Triglycerides | 2 | 2011 | 41 | 0.160 |
Why?
|
| Midwestern United States | 1 | 2018 | 67 | 0.160 |
Why?
|
| Quality of Life | 3 | 2022 | 662 | 0.160 |
Why?
|
| Police | 1 | 2016 | 4 | 0.150 |
Why?
|
| Prisoners | 1 | 2016 | 10 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 959 | 0.140 |
Why?
|
| Depression | 1 | 2020 | 465 | 0.140 |
Why?
|
| Cognition | 2 | 2021 | 1277 | 0.130 |
Why?
|
| Biomarkers | 1 | 2018 | 689 | 0.130 |
Why?
|
| Treatment Failure | 2 | 2013 | 159 | 0.120 |
Why?
|
| Perioperative Nursing | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cathartics | 1 | 2013 | 5 | 0.120 |
Why?
|
| Military Personnel | 1 | 2014 | 34 | 0.120 |
Why?
|
| Prevalence | 2 | 2013 | 487 | 0.120 |
Why?
|
| Nurse-Patient Relations | 1 | 2014 | 40 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 39 | 0.120 |
Why?
|
| Mindfulness | 1 | 2014 | 34 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 66 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2014 | 132 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2019 | 1011 | 0.100 |
Why?
|
| Body Composition | 3 | 2013 | 56 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 78 | 0.100 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2017 | 394 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1113 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2009 | 3478 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2004 | 20 | 0.060 |
Why?
|
| Fasting | 1 | 2004 | 13 | 0.060 |
Why?
|
| Sample Size | 1 | 2004 | 25 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 437 | 0.060 |
Why?
|
| Cholesterol | 1 | 2004 | 50 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2004 | 6 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2004 | 51 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 324 | 0.060 |
Why?
|
| Insulin | 1 | 2004 | 92 | 0.060 |
Why?
|
| Hot Flashes | 1 | 2003 | 16 | 0.060 |
Why?
|
| Plant Preparations | 1 | 2003 | 9 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2004 | 112 | 0.060 |
Why?
|
| Phytotherapy | 1 | 2003 | 15 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 100 | 0.060 |
Why?
|
| Social Problems | 1 | 2023 | 5 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 143 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2004 | 132 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2004 | 139 | 0.060 |
Why?
|
| Food Technology | 1 | 2002 | 1 | 0.060 |
Why?
|
| Food, Genetically Modified | 1 | 2002 | 1 | 0.060 |
Why?
|
| Cell Count | 1 | 2002 | 99 | 0.050 |
Why?
|
| Placebos | 1 | 2002 | 77 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 47 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 5 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 462 | 0.050 |
Why?
|
| Disease Progression | 3 | 2014 | 787 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2022 | 69 | 0.050 |
Why?
|
| HIV | 1 | 2002 | 92 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 148 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 91 | 0.050 |
Why?
|
| Grounded Theory | 1 | 2021 | 5 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 75 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 333 | 0.050 |
Why?
|
| Health Personnel | 1 | 2022 | 115 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 9448 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2021 | 112 | 0.050 |
Why?
|
| Self Report | 1 | 2021 | 218 | 0.050 |
Why?
|
| Nurse Anesthetists | 1 | 2019 | 3 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 428 | 0.040 |
Why?
|
| Mothers | 1 | 2021 | 178 | 0.040 |
Why?
|
| Dementia | 1 | 2004 | 521 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 531 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 35 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 16 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1442 | 0.040 |
Why?
|
| Prisons | 1 | 2016 | 12 | 0.040 |
Why?
|
| Risk | 1 | 2017 | 217 | 0.040 |
Why?
|
| Animals | 1 | 2005 | 4552 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2017 | 227 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 521 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 2014 | 5 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 37 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 43 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 35 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 98 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 175 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 125 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 144 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 111 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2009 | 11 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 63 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1616 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 66 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 77 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 66 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 211 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 1932 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 2004 | 17 | 0.020 |
Why?
|
| Cimicifuga | 1 | 2003 | 1 | 0.020 |
Why?
|
| Soy Foods | 1 | 2003 | 1 | 0.020 |
Why?
|
| Phytoestrogens | 1 | 2003 | 3 | 0.020 |
Why?
|
| Angelica sinensis | 1 | 2003 | 5 | 0.020 |
Why?
|
| Isoflavones | 1 | 2003 | 4 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2003 | 19 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 27 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 45 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 162 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 24 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2002 | 150 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 138 | 0.010 |
Why?
|